Retatrutide is a new medication in the fight against obesity. This novel drug, private label peptides categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, Retatrutide controls cravings, {promotesglucose regulation, and ultimately results in significant weight loss. While stu